Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes

International Journal of Pharmaceutics

Volumn 392, Issue 1-2, 2010, Pages 304-310

  Manosroi, Aranya ^a   Khanrin, Penpan ^a   Lohcharoenkal, Warangkana ^a   Werner, Rolf G ^b   Götz, Friedrich ^c   Manosroi, Worapaka ^a   Manosroi, Jiradej ^a  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Antibacterial; Gallidermin; Niosomes; Transdermal absorption

Indexed keywords

DICETYL PHOSPHATE; GALLIDERMIN; NIOSOME; POLYSORBATE;

ABDOMEN; AGAR DIFFUSION; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DERMIS; DIFFUSION; DRUG ABSORPTION; DRUG FORMULATION; DRUG STABILITY; EPIDERMIS; GEL; IN VITRO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; RAT; SKIN; SKIN ABSORPTION; STAPHYLOCOCCUS AUREUS; STRATUM CORNEUM; ZETA POTENTIAL;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIOCINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMPOUNDING; DRUG STABILITY; LIPOSOMES; MALE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE; PEPTIDES; PROPIONIBACTERIUM ACNES; RATS; RATS, SPRAGUE-DAWLEY; SKIN; SKIN ABSORPTION; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTIES;

EID: 77952726024     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.03.064     Document Type: Article

References (30)

1. Actapharm, 2002. Novel sources of actinomycete diversity for detection of antimicrobial agents with pharmaceutical applications: 12 month scientific report, project no. QLRT-2000-01783 2001-2004 (online). Available: (06.08.09). http://www.actapharm.org/results/Firstyear%20report.doc.
2. Amsden B.G., Goosen M.F.A. Transdermal delivery of peptide and protein drugs: an overview. Am. Chem. Eng. 2004, 41:1972-1997.
3. Biju S.S., Talegaonkar S., Mishra P.R., Khar R.K. Vesicular systems: an overview. Indian J. Pharm. Sci. 2006, 68:141-153.
4. Cevc G., Mazgareanu S., Rother M., Vierl U. Occlusion effect on transcutaneous NSAID delivery from conventional and carrier-based formulations. Int. J. Pharm. 2008, 359:190-197.
5. Cotter P., Hill C., Ross R. Bacterial lantibiotics: strategies to improve therapeutic. Potential Curr. Protein Peptide Sci. 2005, 6:61-75.
6. Ferreira L.S., Ramaldes G.A., Nunan E.A., Ferreira L.A. In vitro skin permeation and retention of paromomycin from liposomes for topical treatment of the cutaneous leishmaniasis. Drug Dev. Ind. Pharm. 2004, 4:289-296.
7. Freund S., Jung G., Gutbrod O., Folkers G., Gibbons W.A. Nisin and Novel Lantibiotics 1991, ESCOM, Leiden, pp. 91-102.
8. Gude R.P., Jadhav M.G., Rao S.G.A., Jagtap A.G. Effects of niosomal cisplatin and combination of the same with theophylline and with activated macrophages in murine B16F10 melanoma model. Cancer Biother. Radiopharm. 2002, 17:183-192.
9. Hans-Georg S., Ralph W.J., Gabriele B. Biosynthesis and biological activities of lantibiotics with unique post-translational modifications. Eur. J. Biochem. 1995, 230:827-853.
10. Hauser H. Trends Pharmacol. Sci. 1982, 3:274-277.
11. James P.A. Comparison of four methods for the determination of MIC and MBC of penicillin for viridans streptococci and the implications for penicillin tolerance. J. Antimicrob. Chemother. 1990, 25:209-216.
12. Kellner R., Jung G., Hörner T., Zähner H., Schnell N., Entian K.D., Götz F. Gallidermin: a new lanthionine-containing polypeptide antibiotic. Eur. J. Biochem. 1988, 177:53-59.
13. Kempf M., Theobald U., Fiedler H. Economic improvement of the fermentative production of gallidermin by Staphylococcus gallinarum. Biotechnol. Lett. 1999, 21:663-667.
14. Kikuchi H., Suzuki N., Ebihara K., Morita H., Ishii Y., Kikuchi A., Sugaya S., Serikawa T., Tanaka K. Gene delivery using liposome technology. J. Control. Release 1999, 62:269-277.
15. Kordel M., Schuller F., Sahl H.-G. Interaction of the pore forming-peptide antibiotics Pep 5, nisin and subtilin with non-energized liposomes. FEBS Lett. 1989, 244:99-102.
16. Kotyńska J., Figaszewski Z.A. Adsorption equilibria between liposome membrane formed of phosphatidylcholine and aqueous sodium chloride solution as a function of pH. Biochim. Biophys. Acta 2005, 1720:22-27.
17. Maher S., McClean S. Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells in vitro. Biochem. Pharmacol. 2006, 71:1289-1298.
18. Mak V.H., Potts R.O., Guy R.H. Does hydration affect intercellular lipid organization in the stratum corneum?. Pharm. Res. 1991, 8:1064-1065.
19. Manosroi A., Wongtrakul P., Manosroi J., Midorikawa U., Hanyu Y., Yuasa M., Sugawara F., Sakai H., Abe M. The entrapment of kojic oleate in bilayer vesicles. Int. J. Pharm. 2005, 298:13-25.
20. Manosroi A., Thathang K., Werner G.R., Schubert R., Manosroi J. Stability of luciferase plasmid entrapped in cationic bilayer vesicles. Int. J. Pharm. 2008, 356:291-299.
21. Manosroi, A., Khanarin, P., Götz, F., Werner, R.G., Manosroi, J., in press. Entrapment enhancement of peptide drugs in niosomes. J. Microencapsul.
22. Masterjohn, C., 2005. Cholesterol's Hydroxyl Group. Retrieved from (19.03.10). http://www.cholesterol-and-health.com/cholesterolchemistry101-thehydroxylgroup.html.
23. McLaughlin S.G., Szabo G., Eisenman G. Divalent ions and the surface potential of charged phospholipid membranes. J. Gen. Physiol. 1971, 58:667-687.
24. Peltonen L., Koistinen P., Karjalainen M., Hakkinen A., Hirvonen J. The effect of cosolvents on the formulation of nanoparticles from low-molecular-weight poly(l)lactide. PharmSciTech 2002, 3:article 32.
25. Plessis J., Egbaria K., Weiner N. Influence of formulation factors on the deposition of liposomal components into the different strata of the skin. J. Soc. Cosmet. Chem. 1992, 43:93-100.
26. Rollema H., Kuipers O., Both P., De Vos W., Siezen R. Improvement of solubility and stability of the antimicrobial peptide nisin by protein engineering. Appl. Environ. Microbiol. 1995, 16:2873-2878.
27. Sahl H.G., Reis M., Eschbach M., Szekat C., Beck-Sickinger A.G., Metzger J., Stevanovic S., Jung G. Nisin and Novel Lantibiotics 1991, ESCOM, Leiden, pp. 332-346.
28. Sondell B., Thornell L.E., Stigbrand T., Egelrud T. Immunolocalization of stratum corneum chymotryptic enzyme in human skin and oral epithelium with monoclonal antibodies: evidence of a proteinase specifically expressed in keratinizing squamous epithelia. J. Histochem. Cytochem. 1994, 42:459-465.
29. Torchilin V., Weissig V. Liposome: A Practical Approach 2003, Oxford University Press, Oxford.
30. Verma P., Chandak R. Development of matrix controlled transdermal delivery systems of pentazocine: in vitro/in vivo performance. Acta Pharm. 2009, 59:171-186.